drugset
drugset / Trial / NCT03830281

A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy

NCT03830281 ↗

Phase 3 Completed 471 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

The reason for this study is to compare the study drug LY900014 to insulin lispro (Humalog) when both are used in insulin pump therapy in adults with type 1 diabetes (T1D).

Timeline

Start
2019-02-14
Primary completion
2020-01-06
Completion
2020-01-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Lispro Protein / enzyme biologic 100 unknown Subcutaneous

Indications

type 1 diabetes mellitus